A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue SUPPL. 1, 2012, Pages 183-193

  Kee, Vicki R ^a   Gilchrist, Brad ^a   Granner, Mark A ^b   Sarrazin, Nicola R ^a   Carnahan, Ryan M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Administrative data; Claims data; Convulsions; Epilepsy; International Classification of Diseases; Seizures; Sensitivity; Specificity; Validity

Indexed keywords

ALGORITHM; ANTICONVULSANT THERAPY; ARTICLE; CONVULSION; DISEASE CLASSIFICATION; ELECTROENCEPHALOGRAM; EPILEPSY; HUMAN; MEDICAL RECORD REVIEW; PREDICTIVE VALUE; PRIORITY JOURNAL; SEIZURE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VALIDATION STUDY;

ALGORITHMS; ANTICONVULSANTS; CANADA; DATABASES, FACTUAL; DRUG MONITORING; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; PREDICTIVE VALUE OF TESTS; SEIZURES; SENSITIVITY AND SPECIFICITY; UNITED STATES; VALIDATION STUDIES AS TOPIC;

EID: 84856040343     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2329     Document Type: Article

References (15)

1. Targeting Epilepsy: Improving the Lives of People with One of the Nation's Most Common Neurological Conditions. At a Glance 2011. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Adult and Community Health. Available at: [7 January 2011]
2. Quaranta LA. Seizures. In: Tisdale JE and Miller DA (eds). Drug-Induced Diseases: Prevention, Detection, and Management. 1st ed. American Society of Health-System Pharmacists: Bethesda, MD, 2005; 111-123.
3. Coleman JJ. Drug-induced seizures. Adverse Drug React Bull 2004; 227: 1-4.
4. Carnahan RM, Moores KG. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012; 21(S1): 82-89.
5. Barlow WE, Davis RL, Glasser JW, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 2001; 345: 656-661. DOI: 10.1056/NEJMoa003077
6. Shui IM, Shi P, Dutta-Linn MM, et al. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine 2009; 27: 5307-5312. DOI: 10.1016/j.vaccine.2009.06.092
7. Zangwill KM, Eriksen E, Lee M, et al. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Pediatrics 2008; 122: e1179-e1185. DOI: 10.1542/peds.2008-1977
8. Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010; 126: e1-e8. DOI: 10.1542/peds.2010-0665
9. Frost FJ, Hurley JS, Petersen HV, et al. A comparison of two methods for estimating the health care costs of epilepsy. Epilepsia 2000; 41: 1020-1026.
10. Holden EW, Grossman E, Nguyen HT, et al. Developing a computer algorithm to identify epilepsy cases in managed care organizations. Dis Manag 2005; 8: 1-14. DOI: 10.1089/dis.2005.8.1
11. Jette N, Reid AY, Quan H, et al. How accurate is ICD coding for epilepsy? Epilepsia 2010; 51: 62-69. DOI: 10.1111/j.1528-1167.2009.02201.x
12. Parko K Thurman DJ. Prevalence of epilepsy and seizures in the Navajo Nation 1998-2002. Epilepsia 2009; 50: 2180-2185. DOI: 10.1111/j.1528-1167.2009.02140.x
13. Pugh MJ, Van Cott AC, Cramer JA, et al. Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004. Neurology 2008; 70: 2171-2178. DOI: 10.1212/01.wnl.0000313157.15089.e6
14. Hardie NA, Garrard J, Gross CR, et al. The validity of epilepsy or seizure documentation in nursing homes. Epilepsy Res 2007; 74: 171-175. DOI: 10.1016/j.eplepsyres.2007.03.008
15. Gardner JS, Blough D, Drinkard CR, et al. Tramadol and seizures: a surveillance study in a managed care population. Pharmacotherapy 2000; 20: 1423-1431.